Yahoo
    OTC Markets OTCQX - Delayed Quote USD

    Verano Holdings Corp. (VRNO)

    Get top stock picks
    1.0900 +0.0300 (+2.86%)
    As of 11:05:48 AM EDT. Market Open.
    Get top stock picks
    Chart Range Bar
    AlphaSpace Chart
    Loading chart for VRNO
    • Previous Close 1.0600
    • Open 1.0700
    • Bid 1.0900 x 900000
    • Ask 1.0900 x 2760000
    • Day's Range 1.0700 - 1.1300
    • 52 Week Range 0.4600 - 1.9500
    • Volume 153,143
    • Avg. Volume 1,091,561
    • Market Cap (intraday) 397.176M
    • Beta (5Y Monthly) 1.43
    • PE Ratio (TTM) --
    • EPS (TTM) -0.5800
    • Earnings Date Apr 30, 2026
    • Forward Dividend & Yield --
    • Ex-Dividend Date --
    • 1y Target Est 5.00

    Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois.

    verano.com

    3,800

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Verano Holdings Corp.

    Recent News: VRNO

    View More
    View More

    Performance Overview: VRNO

    Trailing total returns as of 5/21/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

    YTD Return

    VRNO
    9.17%
    MSCI WORLD (^990100-USD-STRD)
    7.47%

    1-Year Return

    VRNO
    49.32%
    MSCI WORLD (^990100-USD-STRD)
    24.32%

    3-Year Return

    VRNO
    61.36%
    MSCI WORLD (^990100-USD-STRD)
    0.00%

    5-Year Return

    VRNO
    94.26%
    MSCI WORLD (^990100-USD-STRD)
    61.78%

    Earnings Trends: VRNO

    View More

    Earnings Per Share

    GAAP
    Normalized
    GAAP
    Normalized

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q1 FY26
    Revenue 208.18M
    Earnings -590k

    Q2

    FY25

    Q3

    FY25

    Q4

    FY25

    Q1

    FY26

    0
    50M
    100M
    150M
    200M
    View More

    Analyst Insights: VRNO

    View More

    Analyst Price Targets

    5.00
    5.00 Average
    1.0900 Current
    5.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics: VRNO

    View More

    Valuation Measures

    Annual
    As of 4/30/2026

    • Market Cap

      389.56M

    • Enterprise Value

      811.89M

    • Trailing P/E

      --

    • Forward P/E

      --

    • PEG Ratio (5yr expected)

      --

    • Price/Sales (ttm)

      0.57

    • Price/Book (mrq)

      0.56

    • Enterprise Value/Revenue

      1.05

    • Enterprise Value/EBITDA

      36.79

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -32.23%

    • Return on Assets (ttm)

      2.53%

    • Return on Equity (ttm)

      -32.46%

    • Revenue (ttm)

      819.87M

    • Net Income Avi to Common (ttm)

      -264.22M

    • Diluted EPS (ttm)

      -0.5800

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      74.03M

    • Total Debt/Equity (mrq)

      72.29%

    • Levered Free Cash Flow (ttm)

      28.32M

    View More

    Compare To: VRNO

    Compare

    Select to analyze similar companies using key performance metrics; select up to 4 stocks.

    VRNO
    Verano Holdings Corp.
    1.0900
    +2.86%
    Mkt Cap 397.176M
    Industry Drug Manufacturers—Specialty & Generic
    TSNDF
    TerrAscend Corp.
    0.6300
    -1.58%
    Mkt Cap 235.024M
    Industry Drug Manufacturers—Specialty & Generic
    GTBIF
    Green Thumb Industries Inc.
    7.19
    -0.83%
    Mkt Cap 1.575B
    Industry Drug Manufacturers—Specialty & Generic
    CRLBF
    Cresco Labs Inc.
    0.9000
    +2.25%
    Mkt Cap 333.449M
    Industry Drug Manufacturers—Specialty & Generic
    GLASF
    Glass House Brands Inc.
    10.09
    +0.10%
    Mkt Cap 857.098M
    Industry Drug Manufacturers—Specialty & Generic
    CBSTF
    Cannabist Company Holdings Inc
    0.0291
    0.00%
    Mkt Cap 14.476M
    Industry Drug Manufacturers—Specialty & Generic
    TCNNF
    Trulieve Cannabis Corp.
    7.68
    -2.54%
    Mkt Cap 1.477B
    Industry Drug Manufacturers—Specialty & Generic
    CURLF
    Curaleaf Holdings, Inc.
    3.2700
    -1.21%
    Mkt Cap 2.59B
    Industry Drug Manufacturers—Specialty & Generic
    AYRWF
    Ayr Wellness Inc.
    0.0155
    +9.93%
    Mkt Cap 1.81M
    Industry Drug Manufacturers—Specialty & Generic
    JUSHF
    Jushi Holdings Inc.
    0.4993
    +1.92%
    Mkt Cap 99.709M
    Industry Drug Manufacturers—Specialty & Generic
    AAWH
    Ascend Wellness Holdings, Inc.
    0.5448
    +0.91%
    Mkt Cap 110.615M
    Industry Drug Manufacturers—Specialty & Generic

    People Also Watch

    AYRWF Ayr Wellness Inc.
    0.0155 +9.93%
    GLASF Glass House Brands Inc.
    10.09 +0.10%
    AAWH Ascend Wellness Holdings, Inc.
    0.5448 +0.91%
    GTBIF Green Thumb Industries Inc.
    7.19 -0.83%
    JUSHF Jushi Holdings Inc.
    0.4993 +1.92%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: